Inhibiting TRF1 upstream signaling pathways to target telomeres in cancer cells
Abstract In the context of tumorigenesis, telomere shortening is associated with apparent antagonistic outcomes: On one side, it favors cancer initiation through mechanisms involving genome instability, while on the other side, it prevents cancer progression, due to the activation of the DNA damage...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer Nature
2019-06-01
|
Series: | EMBO Molecular Medicine |
Online Access: | https://doi.org/10.15252/emmm.201910845 |